We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

107 hedge funds and large institutions have $1.21B invested in Heron Therapeutics in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,441% more call options, than puts

Call options by funds: $33.4M | Put options by funds: $2.17M

91% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 22

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

14% more capital invested

Capital invested by funds: $1.06B → $1.21B (+$149M)

5% more funds holding

Funds holding: 102 → 107 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
107
Holders Change
+5
Holders Change %
+4.9%
% of All Funds
2.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
31
Increased
42
Reduced
22
Closed
25
Calls
$33.4M
Puts
$2.17M
Net Calls
+$31.3M
Net Calls Change
-$53.5M

Top Buyers

1
JHIU
Janus Henderson Investors US
Colorado
+$14.7M
2
KCM
Kingdon Capital Management
New York
+$10.2M
3
BC
Broadfin Capital
New York
+$9.89M
4
Citadel Advisors
Citadel Advisors
Florida
+$8.8M
5
State Street
State Street
Massachusetts
+$8.74M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$18.4M
2
Group One Trading
Group One Trading
Illinois
-$6.32M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6.02M
4
PHS
PFM Health Sciences
California
-$4.95M
5
SM
Sabby Management
Florida
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
101
Quantbot Technologies
New York
$4K +$4.55K +170 New
DADC
102
D.A. Davidson & Co
Montana
$2K +$2.67K +100 New
TRCT
103
Tower Research Capital (TRC)
New York
$1K +$1.42K +53 New
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$485 +$5.32K +199 +1%
WEC
105
Winslow Evans & Crocker
Massachusetts
$28 – – –
SM
106
Sabby Management
Florida
– -$4.29M -160,323 Closed
HCM
107
Highbridge Capital Management
New York
– -$4.27M -159,571 Closed
Adage Capital Partners
108
Adage Capital Partners
Massachusetts
– -$2.8M -114,700 Closed
TCM
109
Tamarack Capital Management
California
– -$1.83M -75,000 Closed
ARTA
110
A.R.T. Advisors
New York
– -$1.74M -71,138 Closed
D.E. Shaw & Co
111
D.E. Shaw & Co
New York
– -$1.47M -60,281 Closed
Voloridge Investment Management
112
Voloridge Investment Management
Florida
– -$1.28M -52,500 Closed
Tudor Investment Corp
113
Tudor Investment Corp
Connecticut
– -$647K -26,533 Closed
NI
114
Numeric Investors
Massachusetts
– -$561K -23,000 Closed
SIM
115
Spark Investment Management
New York
– -$427K -17,500 Closed
AL
116
Airain Ltd
Guernsey
– -$355K -14,536 Closed
LP
117
LMR Partners
United Kingdom
– -$326K -13,363 Closed
SEI Investments
118
SEI Investments
Pennsylvania
– -$280K -11,483 Closed
BFM
119
Boothbay Fund Management
New York
– -$265K -10,854 Closed
PG
120
PEAK6 Group
Illinois
– -$220K -9,000 Closed
CSS
121
Cubist Systematic Strategies
Connecticut
– -$188K -7,722 Closed
Walleye Trading
122
Walleye Trading
New York
– -$56K -2,300 Closed
Point72 Asset Management
123
Point72 Asset Management
Connecticut
– -$27K -1,100 Closed
CCMH
124
Cornerstone Capital Management Holdings
New York
– -$10K -400 Closed
GXMC
125
Global X Management Company
New York
– -$9K -389 Closed
2 3 4
5
6

HRTX Hedge Fund Activity: Q4 2015 in Review

107 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2015, worth a combined $1.21B — up 14% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new HRTX positions and 25 closed out — a net gain of 6 holders — while 42 added to existing stakes and 22 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $14.7M. The largest seller was Goldman Sachs, cutting an estimated $18.4M.

  • 107 institutional investors held Heron Therapeutics (HRTX) as of Q4 2015, up from 102 in Q3 2015.
  • Funds reported $1.21B of Heron Therapeutics stock for Q4 2015, up 14% quarter-over-quarter.
  • 31 funds opened new Heron Therapeutics positions in Q4 2015 and 25 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2015 was Janus Henderson Investors US, an estimated $14.7M added.
  • The largest Heron Therapeutics seller in Q4 2015 was Goldman Sachs, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2015.